Xtant Medical Holdings (XTNT) Operating Income (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Operating Income for 16 consecutive years, with $2.5 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Operating Income rose 167.28% year-over-year to $2.5 million in Q3 2025; TTM through Sep 2025 was $6.3 million, a 145.33% increase from a year earlier, with the FY2024 full-year figure at -$12.1 million, down 18.86% from the prior year.
• Operating Income was $2.5 million for Q3 2025 at Xtant Medical Holdings, down from $4.6 million in the prior quarter.
• Over five years, Operating Income peaked at $4.6 million in Q2 2025 and troughed at -$3.8 million in Q4 2023.
• A 5-year average of -$1.3 million and a median of -$1.7 million in 2022 frame the typical range for Operating Income.
• Across the five-year window, Operating Income slumped 36520.0% in 2022 and jumped 256.96% in 2025, its largest moves.
• Over 5 years, Operating Income stood at -$1.9 million in 2021, then gained by 9.79% to -$1.7 million in 2022, then slumped by 120.77% to -$3.8 million in 2023, then jumped by 50.55% to -$1.9 million in 2024, then surged by 235.02% to $2.5 million in 2025.
• The last three Operating Income figures came in at $2.5 million (Q3 2025), $4.6 million (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.